Impact of functional ABCG2 polymorphisms on the adverse effects of gefitinib in Japanese patients with non-small-cell lung cancer. - Akasaka K; Kaburagi T; Yasuda S; Ohmori K; Abe K; Sagara H; Ueda Y; Nagao K; Imura J; Imai Y; Akasaka, Keiichi; Kaburagi, Takayuki; et al. (Cancer Chemotherapy & Pharmacology, 2010)